Studies on tumor tissue fragments taken from patients before the initiation of treatment with cisplatin and vinorelbine and two weeks after the end of the treatment cycle showed a statistically significant decrease in MMP2 gene expression compared to the baseline [31]. This evidence concerns the gene MMP2 and neoplasm.